Caricamento...

Manipulation of Hydrocortisone Tablets Leads to Iatrogenic Cushing Syndrome in a 6-Year-Old Girl With CAH

Currently there are no commercially available hydrocortisone formulations for the treatment of children with congenital adrenal hyperplasia (CAH) that allow for smaller doses (0.1-1.25 mg) and incremental adjustments needed to control excess androgen production and avoid the negative effects of over...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Al-Rayess, Heba, Fleissner, Kristin, Jaber, Mu’taz, Brundage, Richard C, Sarafoglou, Kyriakie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7417883/
https://ncbi.nlm.nih.gov/pubmed/32803093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa091
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !